Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Cardiovasculares Carlos III (18)

2022

  1. First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers

    Molecular Therapy - Nucleic Acids, Vol. 28, pp. 124-135

  2. Neuroprotective and Anti-Inflammatory Effects of Linoleic Acid in Models of Parkinson’s Disease: The Implication of Lipid Droplets and Lipophagy

    Cells, Vol. 11, Núm. 15

2020

  1. Decreased salivary lactoferrin levels are specific to Alzheimer's disease

    EBioMedicine, Vol. 57, pp. 102834

2019

  1. Planning to reduce 30-day adverse events after discharge of frail elderly patients with acute heart failure: Design and rationale for the DEED FRAIL-AHF trial

    Emergencias, Vol. 31, Núm. 1, pp. 27-35

2015

  1. Asociación entre tiempo sentado y prevalencia de síndrome metabólico en una población adulta trabajadora: La cohorte AWHS

    Nutricion Hospitalaria, Vol. 32, Núm. 6, pp. 2692-2700

  2. Glycated hemoglobin, fasting insulin and the metabolic syndrome in males. Cross-sectional analyses of the aragon workers health study baseline

    PLoS ONE, Vol. 10, Núm. 8

  3. Lower-normal TSH is associated with better metabolic risk factors: A cross-sectional study on Spanish men

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 25, Núm. 12, pp. 1095-1103

2014

  1. A metabolomic approach to the pathogenesis of ventilator-induced lung injury

    Anesthesiology, Vol. 120, Núm. 3, pp. 694-702

  2. Sedentarismo y su relación con el perfil de riesgo cardiovascular, la resistencia a la insulina y la inflamación

    Revista Espanola de Cardiologia, Vol. 67, Núm. 6, pp. 449-455

2013

  1. Escala para la predicción de la aparición de hipertensión arterial en población activa masculina

    Medicina Clinica, Vol. 140, Núm. 11, pp. 487-492

  2. Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients

    AIDS, Vol. 27, Núm. 5, pp. 687-696

2012

  1. Metabolic syndrome and coronary heart disease among Spanish male workers: A case-control study of MESYAS

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 22, Núm. 6, pp. 510-516

2011

  1. Characterization of host genetic expression patterns in HIV-infected individuals with divergent disease progression

    Virology, Vol. 411, Núm. 1, pp. 103-112

2009

  1. Gender differences in obesity related cardiovascular risk factors in Spain

    Preventive Medicine, Vol. 48, Núm. 2, pp. 134-139

  2. Relación entre el síndrome metabólico y la mortalidad por cardiopatía isquémica en España

    Revista Espanola de Cardiologia, Vol. 62, Núm. 12, pp. 1469-1472

  3. Usefulness of Triglycerides-to-High-Density Lipoprotein Cholesterol Ratio for Predicting the First Coronary Event in Men

    American Journal of Cardiology, Vol. 104, Núm. 10, pp. 1393-1397

1993

  1. TRATAMIENTO Y PROFILAXIS DE LAS PRINCIPALES INFECCIONES ASOCIADAS AL VIRUS DE LA INMUNODEFICIENCIA HUMANA

    Medicina Clinica, Vol. 101, Núm. 13, pp. 505-514

1992

  1. HIV-2 infection in Spain: Report of the first 34 cases [8]

    AIDS